Predicine offers quick COVID-19 RT-PCR and IgM/IgG antibody tests.
• Genome-wide molecular insights
• Workflow flexibility
• Combines breadth and depth
• Designed for biopharma clinical trials
Available in RUO and CLIA-validated assay
From a single sample, we provide low-pass whole genome sequencing (LP-WGS) data combined with broader coverage using WES and/or in-depth profiling using PredicineCARE™ or PredicineATLAS™ focused pan cancer panels, based on tumor fraction from the sample.
We offer pilot program grants to select biopharma and academic partners to empower translational research and clinical studies. To initiate a study, contact us via the form below.